✦ LIBER ✦

Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)

✍ Scribed by D.S. ALBERTS; P.Y. LIU; S.P. WILCZYNSKI; A. JANG; J. MOON; J.H. WARD; J.T. BECK; M. CLOUSER; M. MARKMAN

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Imatinib Mesylate an

✍ Helen K. Chew; William E. Barlow; Kathy Albain; Danika Lew; Allen Gown; Daniel F 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 109 KB

Phase II trial of vinblastine in previou

✍ E.A. Surwit; D.S. Alberts; R.V. O'Toole; V. Graham; E.V. Hannigan; R.L. Stephens 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Phase II trial of vinblastine in previou

✍ E.A. Surwit; D.S. Alberts; R.V. O'Toole; V. Graham; E.V. Hannigan; R.L. Stephens 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Phase II trial of imatinib mesylate in p

✍ Robert L. Coleman; Russell R. Broaddus; Diane C. Bodurka; Judith K. Wolf; Thomas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase II Trial of Pyrazoloacridine in Re

✍ Steven C. Plaxe; John A. Blessing; Michael A. Bookman; William T. Creasman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Phase II trial of amonafide in previousl

✍ Holly H. Gallion; P.Y. Liu; David E. Alberts; Robert V. O'Toole; Janet O'Sulliva 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 320 KB